Indeed, the pharmacological inhibition of DNMTs restored methylation at promoter IV of Bdnf and its transcription in vitro as well as rescued transcription of critical HD-associated genes in R6/2 mice [104]. This evidence concerns the gene BDNF and Huntington disease.